Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma

NCT02176967 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT02176967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02176967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Active, not recruiting
Start date
August 8, 2014
Completion date
October 6, 2027
Enrollment
391 (actual)
Sites
222

Conditions

As the registry lists them; a condition with its own page is linked.

ganglioneuroblastoma, localized resectable neuroblastoma, localized unresectable neuroblastoma, neuroblastoma